1 Neuropathix Inc. Receivables Turnover Ratio (TYGS), from the first quarter 2022 to the first quarter 2021 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Neuropathix Inc.  (TYGS)
 

Neuropathix Accounts Receivables Turnover Ratio from the first quarter 2022 to the first quarter 2021

Quarterly Results, Trends, Rankings, Statistics


Neuropathix Inc.'s ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2022 to a ratio of 39.28, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the first quarter 2022. Average receivable collection period, for the Neuropathix in Mar 31 2022 quarter, has decreased to 9 days, compared to 46 days, in the Dec 31 2021 quarter.

If we take a look into Healthcare sector Neuropathix Inc. achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Neuropathix Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TYGS Receivables Turnover Ratio (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter
Y / Y Receivable Change -99.3 % 0 % 8750 % 0 % 14109.5 %
Y / Y Revenue Change 549.94 % - - - -
Receivable Turnover Ratio (TTM) 39.28 7.89 2.88 2.21 2.21
TYGS's Total Ranking # # # # #
Accounts Receivable average collection period days 9 46 127 165 165
Seq. Receivable Change 0 % -98.87 % 8750 % -99.3 % 14109.5 %
Seq. Revenue Change 78.56 % 232.79 % - - -


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Receivable Turnover Ratio Statistics
High Average Low
0 0 0
 





TYGS Company Profile • Back to TYGS Efficiency Comparisons • Compare TYGS Receivables Turnover Ratio to its Competitors

Financial Statements
Neuropathix's Accounts Receivable $ 0 Millions Visit TYGS's Balance sheet
Neuropathix's Sales TTM $ 0 Millions Visit TYGS's Income Statement
Sources of TYGS's Revenues Visit TYGS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
TYGS's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
TYGS's Growth Rates TYGS's Roa TYGS's Inventory Turnover Ratio TYGS's Dividend Comparisons
TYGS's Profitability Ratios TYGS's Roi TYGS's Asset Turnover Ratio TYGS's Dividend Growth
TYGS's Valuation Ratios TYGS's Roe TYGS's Financial Strength Ratios TYGS's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2022, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2022 Receivable at quarter ending Mar 31 2022
Neuroone Medical Technologies Corp  1,294.98 $ 48.446  Millions$ 0.037  Millions
Adicet Bio Inc   836.78 $ 38.701  Millions$ 0.046  Millions
Abcellera Biologics Inc   698.88 $ 489.043  Millions$ 0.700  Millions
Warby Parker Inc   684.18 $ 555.043  Millions$ 0.811  Millions
Recursion Pharmaceuticals Inc   343.02 $ 12.949  Millions$ 0.038  Millions
Uniqure N v   324.48 $ 525.340  Millions$ 1.619  Millions
Bridgebio Pharma Inc   233.96 $ 70.948  Millions$ 0.303  Millions
Seres Therapeutics Inc   225.03 $ 140.702  Millions$ 0.625  Millions
Bausch Health Companies Inc   223.49 $ 8,325.000  Millions$ 37.250  Millions
H cyte Inc  215.77 $ 1.615  Millions$ 0.007  Millions
Xoma Royalty Corporation  214.09 $ 40.892  Millions$ 0.191  Millions
Precision Biosciences Inc  210.03 $ 102.497  Millions$ 0.488  Millions
Waters Corporation  209.22 $ 2,867.901  Millions$ 13.708  Millions
China Pharma Holdings Inc  194.94 $ 8.888  Millions$ 0.046  Millions

Date modified: 2026-09-18T13:11:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.